Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Pierre Malchair"'
Autor:
Enrique Hernández-Jiménez, Erika P. Plata-Menchaca, Damaris Berbel, Guillem López de Egea, Macarena Dastis-Arias, Laura García-Tejada, Fabrizio Sbraga, Pierre Malchair, Nadia García Muñoz, Alejandra Larrad Blasco, Eva Molina Ramírez, Xose Pérez Fernández, Joan Sabater Riera, Arnau Ulsamer
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionBacteremia is a life-threatening condition that can progress to sepsis and septic shock, leading to significant mortality in the emergency department (ED). The standard diagnostic method, blood culture, is time-consuming and prone to fals
Externí odkaz:
https://doaj.org/article/8374191210b34e6cae49bd7ff3fd318b
Autor:
Pere Millat-Martinez, Arvind Gharbharan, Andrea Alemany, Casper Rokx, Corine Geurtsvankessel, Grigorios Papageorgiou, Nan van Geloven, Carlijn Jordans, Geert Groeneveld, Francis Swaneveld, Ellen van der Schoot, Marc Corbacho-Monné, Dan Ouchi, Francini Piccolo Ferreira, Pierre Malchair, Sebastian Videla, Vanesa García García, Anna Ruiz-Comellas, Anna Ramírez-Morros, Joana Rodriguez Codina, Rosa Amado Simon, Joan-Ramon Grifols, Julian Blanco, Ignacio Blanco, Jordi Ara, Quique Bassat, Bonaventura Clotet, Bàrbara Baro, Andrea Troxel, Jaap Jan Zwaginga, Oriol Mitjà, Bart J. A. Rijnders, CoV-Early study group, COnV-ert study group
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/5846cb1f73074a97acea76ceac3d412c
Autor:
Pere Millat-Martinez, Arvind Gharbharan, Andrea Alemany, Casper Rokx, Corine Geurtsvankessel, Grigorios Papageorgiou, Nan van Geloven, Carlijn Jordans, Geert Groeneveld, Francis Swaneveld, Ellen van der Schoot, Marc Corbacho-Monné, Dan Ouchi, Francini Piccolo Ferreira, Pierre Malchair, Sebastian Videla, Vanesa García García, Anna Ruiz-Comellas, Anna Ramírez-Morros, Joana Rodriguez Codina, Rosa Amado Simon, Joan-Ramon Grifols, Julian Blanco, Ignacio Blanco, Jordi Ara, Quique Bassat, Bonaventura Clotet, Bàrbara Baro, Andrea Troxel, Jaap Jan Zwaginga, Oriol Mitjà, Bart J. A. Rijnders, CoV-Early study group, COnV-ert study group
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-9 (2022)
Abstract Data on convalescent plasma (CP) treatment in COVID-19 outpatients are scarce. We aimed to assess whether CP administered during the first week of symptoms reduced the disease progression or risk of hospitalization of outpatients. Two multic
Externí odkaz:
https://doaj.org/article/98e3af5488ce46408e4660c90f2bdc2f
Autor:
Pierre Malchair, Aurema Otero, Jordi Giol, Xavier Solanich, Thiago Carnaval, Alonso Fernández-Nistal, Ana Sánchez-Gabriel, Carmen Montoto, Ramon Lleonart, Sebastián Videla, on behalf of the ICAT-COVID team
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-15 (2022)
Abstract Background COVID-19 has quickly become a global pandemic with a substantial number of deaths and is a considerable burden for healthcare systems worldwide. Although most cases are paucisymptomatic and limited to the viral infection-related s
Externí odkaz:
https://doaj.org/article/2695d435f50f4693b95d1f29bdba1199
Autor:
Miguel Santin, Irene Barrabeig, Pierre Malchair, Lucia Gonzalez-Luquero, Miguel A. Benitez, Josefina Sabria, Merce Palau-Benavent, Concepcion Cañete, Joan A. Lloret-Queraltó, Maria D. Grijota-Camino, Jordi Dorca, Fernando Alcaide
Publikováno v:
Emerging Infectious Diseases, Vol 24, Iss 6, Pp 1091-1094 (2018)
In Spain, systematic reporting of pulmonary infections with nontuberculous mycobacteria is not mandatory. Therefore, to determine trends, we retrospectively identified cases for January 1994–December 2014 in Catalonia. Over the 21 years, prevalence
Externí odkaz:
https://doaj.org/article/7b4faf29ab384b629d0c4e0be2169c54
Autor:
Pierre Malchair, Maria Labori, Manuel Rubio-Rivas, Joel Salazar-Mendiguchia, Nuria Baixeras, Xavier Corbella
Publikováno v:
European Journal of Case Reports in Internal Medicine, Vol 2, Iss 3 (2015)
Hydroxychloroquine is an antimalarial drug used in many rheumatologic and systemic diseases. Although considered by clinicians to be relatively safe, serious side effects have been documented (retinotoxicity, neuromyotoxicity and cardiotoxicity). We
Externí odkaz:
https://doaj.org/article/aecd9b0e2f1e4f6f97276c33226461ab
Autor:
Pierre Malchair, Jordi Giol, Vanesa García, Orlando Rodríguez, José Carlos Ruibal, Alvaro Zarauza, Ferrán Llopis, Leire Matellán, Tania Bernal, Beatriz Solís, Aurema Otero, Thiago Carnaval, Hector Jofre, Javier Jacob, Xavier Solanich, Arnau Antolí, Gemma Rocamora, Sebastián Videla
Publikováno v:
Clinical Infectious Diseases. 76:1784-1792
Background We aimed to evaluate icatibant, a competitive antagonist of the bradykinin B2 receptors, for the treatment of inpatients with coronavirus disease 2019 (COVID-19) pneumonia admitted in the early hypoxemic stage. Methods The randomized, open
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::df34c05a30914fbe719b4a00564f35d6
https://doi.org/10.1093/cid/ciac984
https://doi.org/10.1093/cid/ciac984
Autor:
Arantxa Albert, Pere Llorens, Alfons Aguirre, Francisco Javier Martín-Sánchez, Silvia Mínguez, Oscar Moreno, Carles Ferré, Adrián Valls, Begoña Espinosa, Oscar Murillo, Isabel Cirera, Adriana Gil, Samuel Rivera, Ferran Llopis, Pierre Malchair, Juan Gonzalez del Castillo, Javier Jacob
Publikováno v:
Journal of Healthcare Quality Research. 38:26-34
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf8aec4674c19fab7a29cf213f71f05e
https://doi.org/10.1016/j.jhqr.2022.05.007
https://doi.org/10.1016/j.jhqr.2022.05.007
Autor:
Pierre, Malchair, Jordi, Giol, Vanesa, García, Orlando, Rodríguez, José Carlos, Ruibal, Alvaro, Zarauza, Ferrán, Llopis, Leire, Matellán, Tania, Bernal, Beatriz, Solís, Aurema, Otero, Thiago, Carnaval, Hector, Jofre, Javier, Jacob, Xavier, Solanich, Arnau, Antolí, Gemma, Rocamora, Sebastián, Videla, Xavier, Corbella
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
We aimed to evaluate icatibant, a competitive antagonist of the bradykinin B2 receptors, for the treatment of inpatients with COVID-19 pneumonia admitted in the early hypoxemic stage.The randomized, open-label clinical trial of icatibant for COVID-19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dea8521b02cca3f119cc89c635bedaf5
https://pubmed.ncbi.nlm.nih.gov/36610464
https://pubmed.ncbi.nlm.nih.gov/36610464
Autor:
Arantxa, Albert, Pere, Llorens, Alfons, Aguirre, Francisco Javier, Martín-Sánchez, Silvia, Mínguez, Oscar, Moreno, Carles, Ferré, Adrián, Valls, Begoña, Espinosa, Oscar, Murillo, Isabel, Cirera, Adriana, Gil, Samuel, Rivera, Ferran, Llopis, Pierre, Malchair, Juan, Gonzalez Del Castillo, Javier, Jacob
Publikováno v:
Journal of healthcare quality research.
COVID-19 pneumonia is a manifestation of SARS-CoV-2 infection and in most cases involves hospital admission. There are recommendations according to which these patients can be discharged without hospital admission, but there is no evidence regarding
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d4b6a9c050bfa7283e8b18174442d432
https://pubmed.ncbi.nlm.nih.gov/35739038
https://pubmed.ncbi.nlm.nih.gov/35739038